As expected, ImPrint+ tumors had significantly higher grade, ER-low, and MP2 class prevalence than ImPrint– tumors, yet they were significantly smaller, consistent with the hypothesis that immunosurveillance and immunoediting of immune-infiltrated tumors may restrict the size of even highly proliferative cancers.31 Here, ESR1 is linked to cancer.